Table 2

Evolution of patients with acute community-acquired pneumonia, possibly of bacterial origin in Yaounde
Evolution HIV negative n=44 HIV positive n=62 p-value
Treatment failure on 3rdday*, n (%) 17/43 (33.3) 14/55 (17.1) 0.137
Loco-regional complications
None, n (%) 26 (59.1) 51 (82.3) 0.008
Parapneumonic pleural effusion, n (%) 5 (11.4) 3 (4.8) 0.271
Purulent pleural effusion, n (%) 7 (15.9) 5 (8.1) 0.229
Lung abscess, n (%) 6 (13.6) 3 (4.8) 0.158
Median duration of hospitalisation, days (IQR) 13 (10-15) 11.5 (8-16) 0.554
Death, n (%) 4 (9.0) 9 (14.5) 0.401
Median time to death, days (IQR) 0.54 (0.15-6.45) 2 (1-10) 0.268

* One HIV negative and seven HIV positive patients had deceased before 3rd day; IQR, interquartile range.

Yone et al.

Yone et al. BMC Pulmonary Medicine 2012 12:46   doi:10.1186/1471-2466-12-46

Open Data